We then applied a multinomial LASSO regression to differentiate between MS OCB+/− and OND, which resulted in logistic models considering CD5, IL-12B, TNFB, MCP-1, CXCL1, CXCL9 and NfL. This evidence concerns the gene IL12B and myeloid sarcoma.